News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,527 Results
Type
Article (40363)
Company Profile (306)
Press Release (649858)
Section
Business (205543)
Career Advice (2105)
Deals (35598)
Drug Delivery (88)
Drug Development (81582)
Employer Resources (171)
FDA (16242)
Job Trends (14948)
News (347826)
Policy (33218)
Tag
Academia (2585)
Alliances (49662)
Alzheimer's disease (1245)
Approvals (16147)
Artificial intelligence (117)
Bankruptcy (354)
Best Places to Work (11551)
Biotechnology (215)
Breast cancer (110)
Cancer (932)
Cardiovascular disease (84)
Career advice (1761)
Cell therapy (205)
Clinical research (64480)
Collaboration (331)
Compensation (168)
COVID-19 (2573)
Data (866)
Diabetes (138)
Diagnostics (6222)
Drug pricing (80)
Earnings (84511)
Employer resources (148)
Events (110020)
Executive appointments (250)
FDA (16690)
Funding (297)
Gene therapy (153)
GLP-1 (581)
Government (4467)
Healthcare (18836)
Infectious disease (2650)
Inflammatory bowel disease (106)
Interviews (333)
IPO (16361)
Job creations (3688)
Job search strategy (1502)
Layoffs (420)
Legal (8143)
Lung cancer (164)
Manufacturing (155)
Medical device (13208)
Medtech (13213)
Mergers & acquisitions (19259)
Metabolic disorders (371)
Neuroscience (1495)
NextGen Class of 2024 (6584)
Non-profit (4543)
Northern California (1222)
Obesity (221)
Opinion (189)
Patents (96)
People (56663)
Phase I (20041)
Phase II (28398)
Phase III (21176)
Pipeline (213)
Postmarket research (2567)
Preclinical (8544)
Radiopharmaceuticals (235)
Rare diseases (187)
Real estate (5952)
Regulatory (21818)
Research institute (2343)
Resumes & cover letters (364)
Southern California (1098)
Startups (3634)
United States (11836)
Vaccines (550)
Weight loss (166)
Date
Today (235)
Last 7 days (857)
Last 30 days (3038)
Last 365 days (36083)
2024 (30829)
2023 (40407)
2022 (51511)
2021 (56063)
2020 (54488)
2019 (47069)
2018 (35502)
2017 (32459)
2016 (31875)
2015 (37929)
2014 (31628)
2013 (26667)
2012 (28932)
2011 (29591)
2010 (27655)
Location
Africa (734)
Arizona (187)
Asia (37457)
Australia (6166)
California (2780)
Canada (1182)
China (211)
Colorado (120)
Connecticut (124)
Europe (80906)
Florida (397)
Georgia (100)
Illinois (316)
Indiana (180)
Kansas (98)
Maryland (524)
Massachusetts (2270)
Michigan (144)
Minnesota (250)
New Jersey (832)
New York (847)
North Carolina (676)
Northern California (1222)
Ohio (129)
Pennsylvania (752)
South America (1117)
Southern California (1098)
Texas (389)
Utah (80)
Washington State (327)
690,527 Results for "actio biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Actio Biosciences to Participate in Upcoming October Investor Conferences
September 25, 2024
·
1 min read
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Business
Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development
Actio Biosciences today announced that Samuel Collins, Ph.D., has joined the company as chief medical officer to oversee all aspects of clinical development, as well as medical and regulatory affairs, for the company’s pipeline of precision medicines.
January 24, 2024
·
2 min read
Biotech Beach
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, announced the completion of a $55 million Series A financing.
September 12, 2023
·
6 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
October 23, 2024
·
6 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - June 14, 2024
Avidity Biosciences, Inc. announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share.
June 13, 2024
·
5 min read
Press Releases
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
October 31, 2024
·
3 min read
Deals
Pulse Biosciences, Inc. Announces Commencement of Rights Offering - June 4, 2024
Pulse Biosciences, Inc. today announced that it has commenced its previously announced rights offering of up to $60,000,000 of units (the “Units,” and each, a “Unit”) at the Initial Price (as defined below).
June 4, 2024
·
7 min read
1 of 69,053
Next
